DNAprint Genomics (DNAG)

[Blue Juggernaut]

Staddek,

Great Post! I agree with almost everything you stated. Option 3 had me LOL!
One point I would add…......you wrote:

Meanwhile, the price per share decreases and each sale of shares at this low pps causes more proportionate dillution. Time is the enemy and each day without significant revenue, or firm contract promising the same is hurtful for us all, investors and management alike. To propose that management is unaware or uncaring of this situation is simply a false statement by some, or a misinterpretation of the business "facts of life" by others. Given posting histories available here, you can apply the appropriate labels, and determine for yourselves the weight to give to the opinions expressed, by me, or any others.

I would add that the desire to succeed does not equal success. You clearly point this out with Doctor Tony’s early attempts at CEO. Moving to modern day I completely agree that without this team we likely would not be here and I have little doubt as to their desire to succeed. The current main question that I have is that our current team has bought 1 company and part of another that both appear to be losing money. As you point out the pps is going down in part due to dilution. Well, part of the dilution issue now is paying for these companies. Bio may pay for itself with an offering or hidden gems but we have to wait and see. It appears that Trace has not only added to our dilution through the purchase but may have added to our continual dilution due to possible negative earnings. The total wisdom of these two moves may or may not be revealed in the next quarterly or for years for that matter; therefore, I’ll reserve further judgment until a later time. As for now I am hopeful for EPO, concerned about earnings, and long on patience. Once again, your last two big posts have been great!

Big Blue